Neomics Pharmaceuticals
益元桓达
Neomics Pharmaceuticals
Biotech/Healthcare
Neomics Pharmaceuticals focuses on developing adoptive immune cell therapies for the treatment of various solid tumors. The company has a comprehensive R&D platform for cell therapy drugs and has developed a leading minicircle DNA synthesis method for gene therapy vectors, a novel and efficient in…
Latest round: Pre Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.